Rest Of The World was the largest of Resmed Inc’s 2 reported lines in fiscal 2026, at $2.27B — 56% of $4.04B.
| Segment | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | — | $1.20B | $1.34B | $1.77B | |||||||||||
| Rest Of The World | $1.50B | $1.84B | $2.00B | $2.27B | |||||||||||
| Rest Of World | — | — | — | — | |||||||||||
| United States | — | — | — | — | |||||||||||
| U.S., Canada & Latin America | $1.04B | — | — | — | |||||||||||
| North & Latin America | — | — | — | — | |||||||||||
| Combined Europe, Asia & Other Markets | $1.24B | — | — | — | |||||||||||
| Global Revenue | — | — | — | — | |||||||||||
| Global | — | — | — | — | |||||||||||
| Germany | — | — | — | — | |||||||||||
| France | — | — | — | — | |||||||||||
| Australia | — | — | — | — | |||||||||||
| Total | $3.78B | $3.04B | $3.35B | $4.04B |
In fiscal 2026, which ended June 30, 2026, the 2 segments Resmed Inc reported in this breakdown added up to $4.04B. That is less than the $4.43B in its breakdown by segment, so these segments do not account for all of its revenue that year. Rest Of The World was the largest segment, at $2.27B or 56.2% of the total, followed by Americas ($1.77B, 43.8%).
Compared with fiscal 2025, Americas grew the fastest, rising 31.6% to $1.77B.
Americas was first reported as a separate segment in fiscal 2024. The table also keeps 10 segments that Resmed Inc no longer reports, so earlier years can still be read on their original basis; use "Show 10 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2012 to 2026, as reported in Resmed Inc's annual filings.
Sleep & Breathing Health was the largest of Resmed Inc’s 2 reported lines in fiscal 2026, at $3.21B — 83% of $3.89B.
| Statement Business Segments | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sleep & Breathing Health | $1.44B | $1.52B | $1.65B | $3.21B | ||||||
| Sleep & Respiratory Care | — | — | — | — | ||||||
| Sleep & Respiratory Care Products | — | — | — | — | ||||||
| Devices | — | — | — | — | ||||||
| Masks & Other | — | — | — | — | ||||||
| Residential Care Software | $497.98M | $584.13M | $641.44M | $675.81M | ||||||
| Software As A Service | — | — | — | — | ||||||
| Total | $1.94B | $2.11B | $2.30B | $3.89B |
In fiscal 2026, which ended June 30, 2026, the 2 segments Resmed Inc reported in this breakdown added up to $3.89B. That is less than the $4.43B in its breakdown by segment, so these segments do not account for all of its revenue that year. Sleep & Breathing Health was the largest segment, at $3.21B or 82.6% of the total, followed by Residential Care Software ($675.81M, 17.4%).
Compared with fiscal 2025, Sleep & Breathing Health grew the fastest, rising 94.0% to $3.21B.
The table also keeps 5 segments that Resmed Inc no longer reports, so earlier years can still be read on their original basis; use "Show 5 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2017 to 2026, as reported in Resmed Inc's annual filings.
Masks & Other was the largest of Resmed Inc’s 2 reported lines in fiscal 2026, at $2.66B — 60% of $4.43B.
| Subsegments | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2026 |
|---|---|---|---|---|---|
| Masks & Other | $1.87B | $2.66B | |||
| Devices | $1.44B | $1.77B | |||
| Total | $3.31B | $4.43B |
In fiscal 2026, which ended June 30, 2026, the 2 segments Resmed Inc reported in this breakdown added up to $4.43B. That was up 33.5% from $3.31B in fiscal 2023, the latest earlier year this breakdown was reported. Masks & Other was the largest segment, at $2.66B or 60.1% of the total, followed by Devices ($1.77B, 39.9%).
Compared with fiscal 2023, the latest earlier year reported, Masks & Other grew the fastest, rising 42.1% to $2.66B. Over fiscal 2023 to 2026, revenue across these segments went from $3.31B to $4.43B, a compound annual growth rate of 10.1%. Masks & Other's share of the total rose from 56.4% to 60.1% over the same years.
This breakdown covers 5 fiscal years between 2020 and 2026, as reported in Resmed Inc's annual filings.
Resmed Inc (RMD) breaks its revenue down by segment. In fiscal 2026, its largest segment was Rest Of The World, with $2.27B or 56.2% of the total, followed by Americas at $1.77B (43.8%).
Rest Of The World was Resmed Inc's largest segment in fiscal 2026, with $2.27B in revenue, 56.2% of the $4.04B reported across its 2 segments.
Of the Resmed Inc segments reported in both fiscal 2025 and fiscal 2026, and making up at least 2% of the total, Americas grew the fastest, rising 31.6% from $1.34B to $1.77B.
Every figure is taken from Resmed Inc's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2012 to 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.